Multiple Assemblies exist for SMTL entry 4cby
Design, synthesis, and biological evaluation of potent and selective Class IIa HDAC inhibitors as a potential therapy for Huntington's disease; X-RAY DIFFRACTION 2.72 Å

	SMTL ID 4cby.1 Ligands (1R,2R,3R)-2-[4-(1,3-oxazol-5-yl)phenyl]-N-oxidanyl-3-phenyl-cyclopropane-1-carboxamide; ZINC ION; SODIUM ION Polypeptides HISTONE DEACETYLASE 4 Oligo-state monomer
	SMTL ID 4cby.2 Ligands (1R,2R,3R)-2-[4-(1,3-oxazol-5-yl)phenyl]-N-oxidanyl-3-phenyl-cyclopropane-1-carboxamide; ZINC ION; SODIUM ION Polypeptides HISTONE DEACETYLASE 4 Oligo-state monomer
	SMTL ID 4cby.3 Ligands (1R,2R,3R)-2-[4-(1,3-oxazol-5-yl)phenyl]-N-oxidanyl-3-phenyl-cyclopropane-1-carboxamide; ZINC ION; SODIUM ION Polypeptides HISTONE DEACETYLASE 4 Oligo-state monomer
	SMTL ID 4cby.4 Ligands (1R,2R,3R)-2-[4-(1,3-oxazol-5-yl)phenyl]-N-oxidanyl-3-phenyl-cyclopropane-1-carboxamide; ZINC ION; SODIUM ION Polypeptides HISTONE DEACETYLASE 4 Oligo-state monomer